Emerging treatment option for patients with advanced disease
New results from the BLASST-1 trial show increases in downstaging and relapse-free survival
Study highlights value of preoperative imaging to guide surgical decision-making
How a novel tissue marker makes a difference
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Model identifies target OS at which economic benefits of treatment outpace placebo
Setting a new benchmark for control arm estimates
Overall survival benefit not established
In search of improved outcomes for patients
An overview of our leading-edge diagnostics and therapeutics
Multi-institutional registry analysis highlights need for further research